title: Damage-induced cell-cell communication in different cochlear cell types via two distinct ATP-dependent Ca waves.
abstract: Intercellular Ca(2+) waves can coordinate the action of large numbers of cells over significant distances. Recent work in many different systems has indicated that the release of ATP is fundamental for the propagation of most Ca(2+) waves. In the organ of hearing, the cochlea, ATP release is involved in critical signalling events during tissue maturation. ATP-dependent signalling is also implicated in the normal hearing process and in sensing cochlear damage. Here, we show that two distinct Ca(2+) waves are triggered during damage to cochlear explants. Both Ca(2+) waves are elicited by extracellular ATP acting on P2 receptors, but they differ in their source of Ca(2+), their velocity, their extent of spread and the cell type through which they propagate. A slower Ca(2+) wave (14 mum/s) communicates between Deiters' cells and is mediated by P2Y receptors and Ca(2+) release from IP(3)-sensitive stores. In contrast, a faster Ca(2+) wave (41 mum/s) propagates through sensory hair cells and is mediated by Ca(2+) influx from the external environment. Using inhibitors and selective agonists of P2 receptors, we suggest that the faster Ca(2+) wave is mediated by P2X(4) receptors. Thus, in complex tissues, the expression of different receptors determines the propagation of distinct intercellular communication signals.
  
  
  BACKGROUND
  The online version of this article (doi:10.1007/s11302-010-9193-8) contains supplementary material, which is available to authorized users.
authors.forename: Manuela
authors.initials: M
authors.lastname: Lahne
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Gale
references.citation: J Biol Chem. 1996 Nov 15;271(46):29080-7
references.pmid: 8910562
references.citation: Development. 2007 Apr;134(7):1407-17
references.pmid: 17329369
references.citation: Mol Pharmacol. 1997 Jan;51(1):109-18
references.pmid: 9016352
references.citation: Physiology (Bethesda). 2007 Apr;22:131-44
references.pmid: 17420304
references.citation: Hear Res. 1999 Feb;128(1-2):190-6
references.pmid: 10082298
references.citation: Cell Calcium. 2007 Jan;41(1):77-86
references.pmid: 16828497
references.citation: Science. 1996 May 3;272(5262):735-8
references.pmid: 8614837
references.citation: J Physiol. 1990 Sep;428:109-31
references.pmid: 2172519
references.citation: Cell Calcium. 1993 Mar;14(3):245-54
references.pmid: 8500138
references.citation: J Neurophysiol. 1990 May;63(5):1068-74
references.pmid: 2358862
references.citation: Science. 1999 Apr 9;284(5412):339-43
references.pmid: 10195903
references.citation: J Assoc Res Otolaryngol. 2002 Sep;3(3):248-68
references.pmid: 12382101
references.citation: Nature. 2007 Nov 1;450(7166):50-5
references.pmid: 17972875
references.citation: N Engl J Med. 1993 Oct 7;329(15):1092-102
references.pmid: 8371732
references.citation: J Neurobiol. 2004 Nov;61(2):250-66
references.pmid: 15389694
references.citation: J Neurosci Res. 2004 Nov 1;78(3):383-92
references.pmid: 15389832
references.citation: J Neurosci. 2008 May 7;28(19):4918-28
references.pmid: 18463245
references.citation: Stroke. 2007 Feb;38(2 Suppl):674-6
references.pmid: 17261713
references.citation: J Neurosci. 2008 Oct 1;28(40):9939-52
references.pmid: 18829952
references.citation: J Comp Neurol. 2005 Apr 4;484(2):133-43
references.pmid: 15736235
references.citation: Mol Pharmacol. 2004 Apr;65(4):979-85
references.pmid: 15044628
references.citation: Brain Res Dev Brain Res. 2001 Feb 28;126(2):173-82
references.pmid: 11248351
references.citation: J Neurosci. 2003 Mar 15;23(6):2348-56
references.pmid: 12657694
references.citation: Br J Pharmacol. 1997 Aug;121(7):1445-53
references.pmid: 9257926
references.citation: Audiol Neurootol. 2003 Jan-Feb;8(1):28-37
references.pmid: 12566690
references.citation: Mol Pharmacol. 2007 Dec;72(6):1447-56
references.pmid: 17785580
references.citation: Ann N Y Acad Sci. 1999 Nov 28;884:389-409
references.pmid: 10842609
references.citation: J Neurosci. 2001 Apr 1;21(7):2215-23
references.pmid: 11264297
references.citation: Mol Pharmacol. 1998 Jun;53(6):969-73
references.pmid: 9614197
references.citation: J Neurosci. 1999 Aug 15;19(16):6918-29
references.pmid: 10436049
references.citation: Cell Calcium. 2009 Aug;46(2):136-46
references.pmid: 19631380
references.citation: Mol Pharmacol. 1999 Oct;56(4):720-7
references.pmid: 10496954
references.citation: J Pharmacol Exp Ther. 2001 Mar;296(3):1043-50
references.pmid: 11181939
references.citation: J Comp Neurol. 2000 Jun 5;421(3):289-301
references.pmid: 10813788
references.citation: Br J Pharmacol. 2000 Jan;129(2):388-94
references.pmid: 10694247
references.citation: Science. 1995 Feb 3;267(5198):707-11
references.pmid: 7839151
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18770-5
references.pmid: 19047635
references.citation: Br J Pharmacol. 2003 Dec;140(7):1177-86
references.pmid: 14581177
references.citation: Mol Pharmacol. 2002 Oct;62(4):957-66
references.pmid: 12237343
references.citation: Curr Biol. 2004 Mar 23;14(6):526-9
references.pmid: 15043820
references.citation: Cell Calcium. 2001 Mar;29(3):191-8
references.pmid: 11162856
references.citation: Neuroreport. 2002 Oct 28;13(15):1979-84
references.pmid: 12395104
references.citation: J Neurosci. 1998 Sep 15;18(18):7152-9
references.pmid: 9736638
references.citation: J Neurosci. 1999 Oct 1;19(19):8377-88
references.pmid: 10493739